Advances in Motion

Skip to content

Posts by Jillian Egan, MD

  • While classic serum tumor markers like α-fetoprotein and b-HCG are the gold standard for managing testicular germ cell tumors, microRNA are emerging as promising biomarkers with superior performance. Circulating tumor DNA and circulating tumor cells may prove to be important with further study.

    Oncology, Urology

    Journal

Biography

Jillian Egan, MD, is a urologic oncology fellow in the Department of Urology at Massachusetts General Hospital.

Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program

Physicians in the Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program specialize in using advanced surgical therapies and minimally invasive procedures to treat male and female genitourinary cancers.

Resource links

  • Mass General Cancer Center